A Personalized Mobile Application Providing Temperature-Related Health Risk Warnings and Protective Recommendations for Patients With Chronic Obstructive Pulmonary Disease
Condition(s) studied
Investigational drug(s) / intervention(s)
Mobile Application-Based Personalized Temperature Health Risk Early Warning Intervention: This study implements a digital early warning intervention targeting personalized temperature-related health risks. The mobile application integrates real-time meteorological data and individual characteristics to generate risk levels and deliver tailored health alerts and guidance aimed at supporting risk management and reducing exposure-related health risks.
Study summary
This study will test whether a personalized mobile application that provides temperature-related health risk warnings and protective recommendations can reduce acute exacerbations in people with chronic obstructive pulmonary disease (COPD). Researchers will compare participants who receive the mobile application in addition to usual care with those who receive usual care alone. The main question is whether the mobile application reduces the number of COPD acute exacerbation events over 12 months. The study will also evaluate secondary outcomes including quality of life, functional capacity, symptoms, psychological status, physiological and biochemical indicators, environmental temperature risk perception, and participants' use of the mobile application.
Eligibility
Primary outcome measure(s)
- Number of COPD Acute Exacerbations — 12 months after baseline
Total number of acute exacerbations of COPD managed at home, via outpatient visits, emergency department visits, or hospitalizations.
Trial sites (4)
| Facility | City | Region | Status |
|---|---|---|---|
| Beijing Anzhen Hospital, Capital Medical University | Beijing | China | Recruiting |
| Beijing Huairou Hospital | Beijing | China | Recruiting |
| Civil Aviation General Hospital | Beijing | China | Recruiting |
| Emergency General Hospital | Beijing | China | Recruiting |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07656142 on ClinicalTrials.gov ↗ ← All trials in China